4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0000950170-25-044347
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 2025-03-21 | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | D | ||
Loading xslF345X05/ownership.xml…